Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9764056rdf:typepubmed:Citationlld:pubmed
pubmed-article:9764056lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:9764056lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9764056lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:9764056lifeskim:mentionsumls-concept:C0155626lld:lifeskim
pubmed-article:9764056lifeskim:mentionsumls-concept:C0003280lld:lifeskim
pubmed-article:9764056lifeskim:mentionsumls-concept:C0019139lld:lifeskim
pubmed-article:9764056lifeskim:mentionsumls-concept:C0520997lld:lifeskim
pubmed-article:9764056lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9764056lifeskim:mentionsumls-concept:C0878354lld:lifeskim
pubmed-article:9764056pubmed:issue1lld:pubmed
pubmed-article:9764056pubmed:dateCreated1998-10-14lld:pubmed
pubmed-article:9764056pubmed:abstractTextTo investigate the feasibility of fixed dose, weight adjusted subcutaneous low molecular weight heparin (LMWH), with monitoring of anti-Xa levels and assessment of coronary patency rates after three to five days, thereby giving an initial indication of its safety and efficacy.lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:languageenglld:pubmed
pubmed-article:9764056pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9764056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9764056pubmed:statusMEDLINElld:pubmed
pubmed-article:9764056pubmed:monthJullld:pubmed
pubmed-article:9764056pubmed:issn1355-6037lld:pubmed
pubmed-article:9764056pubmed:authorpubmed-author:LimK AKAlld:pubmed
pubmed-article:9764056pubmed:authorpubmed-author:LeviMMlld:pubmed
pubmed-article:9764056pubmed:authorpubmed-author:AdamsRRlld:pubmed
pubmed-article:9764056pubmed:authorpubmed-author:GallesH MHMlld:pubmed
pubmed-article:9764056pubmed:authorpubmed-author:PrinsM HMHlld:pubmed
pubmed-article:9764056pubmed:authorpubmed-author:PetersR JRJlld:pubmed
pubmed-article:9764056pubmed:authorpubmed-author:de WinterR...lld:pubmed
pubmed-article:9764056pubmed:authorpubmed-author:ChamuleauS...lld:pubmed
pubmed-article:9764056pubmed:issnTypePrintlld:pubmed
pubmed-article:9764056pubmed:volume80lld:pubmed
pubmed-article:9764056pubmed:ownerNLMlld:pubmed
pubmed-article:9764056pubmed:authorsCompleteYlld:pubmed
pubmed-article:9764056pubmed:pagination35-9lld:pubmed
pubmed-article:9764056pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:meshHeadingpubmed-meshheading:9764056-...lld:pubmed
pubmed-article:9764056pubmed:year1998lld:pubmed
pubmed-article:9764056pubmed:articleTitleLow molecular weight heparin as an adjunct to thrombolysis for acute myocardial infarction: the FATIMA study. Fraxiparin Anticoagulant Therapy in Myocardial Infarction Study Amsterdam (FATIMA) Study Group.lld:pubmed
pubmed-article:9764056pubmed:affiliationDepartment of Cardiology, University of Amsterdam, Netherlands.lld:pubmed
pubmed-article:9764056pubmed:publicationTypeJournal Articlelld:pubmed